BoxaGrippal 200 mg/30 mg film-coated tablets are used for the symptomatic relief of nasal congestion accompanied by headache and/or fever in flu-like infections in adults and adolescents aged 15 years and over.
€16.45
Content:
20 Stück
(€0.82 / 1 Stück)
(May vary by country)
Available, delivery time: 1-3 days ⁴
Product number:
RA3931816
Stück:
Manufacturer:
Angelini Pharma Österreich GmbH
Brigittenauer Lände 50-54, 1200 Wien, Österreich
Product information "BoxaGrippal® 200 mg/30 mg film-coated tablets"
BoxaGrippal 200 mg/30 mg - film-coated tablets are used for the symptomatic relief of nasal congestion accompanied by headache and/or fever in flu-like infections in adults and adolescents aged 15 years and over.
BoxaGrippal® 200 mg/30 mg - film-coated tablets contain two active substances: Ibuprofen and pseudoephedrine hydrochloride. Ibuprofen belongs to the group of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). Non-steroidal anti-inflammatory drugs have a pain-relieving and antipyretic effect. Pseudoephedrine hydrochloride belongs to the group of medicines known as vasoconstrictors, whose vasoconstrictive effect causes swelling of the nasal mucosa to subside.
You should only use this combination medicine if you have a blocked nose as well as pain or fever. If you only have one of these symptoms, please talk to your doctor or pharmacist about treatment with ibuprofen or pseudoephedrine hydrochloride only. If you do not feel better or even worse after 5 days, consult your doctor.
Dosage form
Film-coated tablets
How to use
- This medicine is intended for short-term use only. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. If you have an infection, consult a doctor immediately if symptoms (e.g. fever and pain) persist or worsen. Do not take BoxaGrippal 200 mg/30 mg - film-coated tablets for more than 5 days without medical advice.
- The recommended dose is: Adults and adolescents aged 15 years and over should take 1 film-coated tablet every 6 hours if necessary. For more severe symptoms, take 2 tablets every 6 hours if necessary. A maximum daily dose of 6 film-coated tablets (corresponding to 1,200 mg ibuprofen and 180 mg pseudoephedrine hydrochloride) must never be exceeded. Take the film-coated tablets whole with a glass of water, preferably with meals.
- Use in children and adolescents: BoxaGrippal 200 mg/30 mg - Film-coated tablets must not be used in children and adolescents under 15 years of age. If this medicine is required for longer than 3 days in adolescents or if symptoms worsen, a doctor should be consulted.
Ingredients
- The active ingredients are: 1 film-coated tablet contains 200 mg ibuprofen and 30 mg pseudoephedrine hydrochloride.
- The other ingredients are Tablet core: lactose monohydrate, microcrystalline cellulose, carboxymethyl starch sodium (type A), anhydrous highly dispersed silicon dioxide, magnesium stearate. Tablet coating: polyvinyl alcohol, titanium dioxide (E 171), macrogol 3350, talc.
| Piece: | 20 |
|---|---|
| Sugar-free: | Yes |
Read more
No reviews found. Share your insights with others.
Warnings - BoxaGrippal® 200 mg/30 mg film-coated tablets
Instructions for use
| Type of use: | Unzerkaut zu den Mahlzeiten mit viel Wasser einnehmen |
|---|---|
| Field of use: | Symptomatisch bei verstopfter Nase und Nebenhöhlen Rhinosinusitis mit Erkältungsbeschwerden |
| Dosage: | Möglichst kurzzeitig und niedrig dosiert anwenden u Personen ab 15 Jahrenu ED 1 FT, bei starken Symptomen ED 2 FT, ev alle 6 Std wiederholen MTD 6 FT Maximale Anwendungsdauer 5 Tage, bei Jugendlichen 3 Tage |
| Properties and efficacy: | Kombination Antiphlogistikum Sympathomimetikum |
| Contraindications: | LogImport.sisx.GAD.Analgetika-Überempfindlichkeit, peptische Ulzera oder Blutungen, Blutbildungsstörungen, schwere Herz-, Leber-, Niereninsuffizienz, aktive Blutungen, Tachyarrhythmie, schwere Hypertonie, Hyperthyreose, Schlaganfall und Risikofaktoren, |
| Habituation effects: | LogImport.sisx.GED.Toleranz und Missbrauch möglich |
| Side effects: | MagenDarm Blutungen, ischämische Kolitis, Überempfindlichkeit Asthma, Dermatosen, schwere Hautreaktionen, Auge Sehstörungen, ischämische Optikusneuropathie, Kounis-Syndrom, posteriores reversibles Enzephalopathiesyndrom, reversibles |
| Special warnings for safe use: | Vorsicht bei Mischkollagenosen, Porphyrie, schweren Herzerkrankungen hohe Dosen vermeiden Positive Dopingtests möglich Auf schwere Hautreaktionen, Sehstörungen achten Maximaldosis nicht überschreiten Bei Varizellen-Infektionen nicht |
| Interactions: | uKontraindiziertu MAO-Hemmer 2 Wochen Abstand, andere Vasokonstriktoren zB Bromocriptin, Pergolid, Lisurid, Cabergolin, Ergotamin, Dihydroergotamin, andere Dekongestiva zB Phenylpropanolamin, Phenylephrin, Ephedrin, Ergotalkaloide uN |
| Pregnancy and breastfeeding period: | Wenn im 1 und 2 Trimenon unbedingt notwendig, nur kurzzeitig und niedrig dosiert anwenden Gegenanzeige im 3 Trimenon Strenge NutzenRisiko-Abwägung in der Stillzeit |
Pregnancy information
| Use forbidden |
|---|
| Use only if absolutely or vitally indicated |
Breastfeeding information
| Breastfeeding forbidden |
|---|
| Breastfeeding only if absolutely or vitally indicated |
Pictograms
| Take with meals |
|---|
| Caution for diabetics |
| Take intact |
| Caution: may affect ability to drive/use machines |
| Avoid alcohol intake |
| Conditionally forbidden for squad athletes; special rules apply. |
Product recommendations for you